184 related articles for article (PubMed ID: 11504093)
41. [
Amor-Coarasa A; Kelly J; Ponnala S; Vedvyas Y; Nikolopoulou A; Williams C; Jin MM; David Warren J; Babich JW
Nucl Med Biol; 2018 May; 60():37-44. PubMed ID: 29544122
[TBL] [Abstract][Full Text] [Related]
42. Determination of residual Kryptofix 2.2.2 levels in [18F]-labeled radiopharmaceuticals for human use.
Scott PJ; Kilbourn MR
Appl Radiat Isot; 2007 Dec; 65(12):1359-62. PubMed ID: 17582776
[TBL] [Abstract][Full Text] [Related]
43. Synthesis and Preclinical Evaluation of Three Novel Fluorine-18 Labeled Radiopharmaceuticals for P-Glycoprotein PET Imaging at the Blood-Brain Barrier.
Savolainen H; Cantore M; Colabufo NA; Elsinga PH; Windhorst AD; Luurtsema G
Mol Pharm; 2015 Jul; 12(7):2265-75. PubMed ID: 26043236
[TBL] [Abstract][Full Text] [Related]
44. In vivo biodistribution and pharmacokinetics of 18F-labelled Spiegelmers: a new class of oligonucleotidic radiopharmaceuticals.
Boisgard R; Kuhnast B; Vonhoff S; Younes C; Hinnen F; Verbavatz JM; Rousseau B; Fürste JP; Wlotzka B; Dollé F; Klussmann S; Tavitian B
Eur J Nucl Med Mol Imaging; 2005 Apr; 32(4):470-7. PubMed ID: 15614506
[TBL] [Abstract][Full Text] [Related]
45. New Clinical Indications for (18)F/(11)C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature.
Evangelista L; Briganti A; Fanti S; Joniau S; Reske S; Schiavina R; Stief C; Thalmann GN; Picchio M
Eur Urol; 2016 Jul; 70(1):161-175. PubMed ID: 26850970
[TBL] [Abstract][Full Text] [Related]
46. Sulfonyl fluoride-based prosthetic compounds as potential 18F labelling agents.
Inkster JA; Liu K; Ait-Mohand S; Schaffer P; Guérin B; Ruth TJ; Storr T
Chemistry; 2012 Aug; 18(35):11079-87. PubMed ID: 22807282
[TBL] [Abstract][Full Text] [Related]
47. Single-Cell Imaging Using Radioluminescence Microscopy Reveals Unexpected Binding Target for [18F]HFB.
Kiru L; Kim TJ; Shen B; Chin FT; Pratx G
Mol Imaging Biol; 2018 Jun; 20(3):378-387. PubMed ID: 29143174
[TBL] [Abstract][Full Text] [Related]
48. 18F-labeled styrylpyridines as PET agents for amyloid plaque imaging.
Zhang W; Kung MP; Oya S; Hou C; Kung HF
Nucl Med Biol; 2007 Jan; 34(1):89-97. PubMed ID: 17210465
[TBL] [Abstract][Full Text] [Related]
49. Synthesis of 11C, 18F, 15O, and 13N radiolabels for positron emission tomography.
Miller PW; Long NJ; Vilar R; Gee AD
Angew Chem Int Ed Engl; 2008; 47(47):8998-9033. PubMed ID: 18988199
[TBL] [Abstract][Full Text] [Related]
50. Improved kinetic stability of DTPA- dGlu as compared with conventional monofunctional DTPA in chelating indium and yttrium: preclinical and initial clinical evaluation of radiometal labelled minigastrin derivatives.
Béhé M; Becker W; Gotthardt M; Angerstein C; Behr TM
Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1140-6. PubMed ID: 12768330
[TBL] [Abstract][Full Text] [Related]
51. Systematic comparison of two novel, thiol-reactive prosthetic groups for 18F labeling of peptides and proteins with the acylation agent succinimidyl-4-[18F]fluorobenzoate ([18F]SFB).
Wuest F; Köhler L; Berndt M; Pietzsch J
Amino Acids; 2009 Feb; 36(2):283-95. PubMed ID: 18414978
[TBL] [Abstract][Full Text] [Related]
52. A Promising PET Tracer for Imaging of α₇ Nicotinic Acetylcholine Receptors in the Brain: Design, Synthesis, and in Vivo Evaluation of a Dibenzothiophene-Based Radioligand.
Teodoro R; Scheunemann M; Deuther-Conrad W; Wenzel B; Fasoli FM; Gotti C; Kranz M; Donat CK; Patt M; Hillmer A; Zheng MQ; Peters D; Steinbach J; Sabri O; Huang Y; Brust P
Molecules; 2015 Oct; 20(10):18387-421. PubMed ID: 26473809
[TBL] [Abstract][Full Text] [Related]
53. In vitro and in vivo evaluation of [18F]ciprofloxacin for the imaging of bacterial infections with PET.
Langer O; Brunner M; Zeitlinger M; Ziegler S; Müller U; Dobrozemsky G; Lackner E; Joukhadar C; Mitterhauser M; Wadsak W; Minar E; Dudczak R; Kletter K; Müller M
Eur J Nucl Med Mol Imaging; 2005 Feb; 32(2):143-50. PubMed ID: 15690222
[TBL] [Abstract][Full Text] [Related]
54. 68Ga-PET radiopharmacy: A generator-based alternative to 18F-radiopharmacy.
Maecke HR; André JP
Ernst Schering Res Found Workshop; 2007; (62):215-42. PubMed ID: 17172157
[TBL] [Abstract][Full Text] [Related]
55. [18F]fluorination of o-carborane via nucleophilic substitution: towards a versatile platform for the preparation of 18F-labelled BNCT drug candidates.
Gona KB; Gómez-Vallejo V; Padro D; Llop J
Chem Commun (Camb); 2013 Dec; 49(98):11491-3. PubMed ID: 24175318
[TBL] [Abstract][Full Text] [Related]
56. Synthesis, 18F-Radiolabelling and Biological Characterization of Novel Fluoroalkylated Triazine Derivatives for in Vivo Imaging of Phosphodiesterase 2A in Brain via Positron Emission Tomography.
Schröder S; Wenzel B; Deuther-Conrad W; Teodoro R; Egerland U; Kranz M; Scheunemann M; Höfgen N; Steinbach J; Brust P
Molecules; 2015 May; 20(6):9591-615. PubMed ID: 26016549
[TBL] [Abstract][Full Text] [Related]
57. F-18 Polyethyleneglycol stilbenes as PET imaging agents targeting Abeta aggregates in the brain.
Zhang W; Oya S; Kung MP; Hou C; Maier DL; Kung HF
Nucl Med Biol; 2005 Nov; 32(8):799-809. PubMed ID: 16253804
[TBL] [Abstract][Full Text] [Related]
58. Imaging of tumour hypoxia using PET and 18F-labelled tracers: biology meets technology.
Grönroos T; Minn H
Eur J Nucl Med Mol Imaging; 2007 Oct; 34(10):1563-5. PubMed ID: 17598110
[No Abstract] [Full Text] [Related]
59. Fluorinated tracers for imaging cancer with positron emission tomography.
Couturier O; Luxen A; Chatal JF; Vuillez JP; Rigo P; Hustinx R
Eur J Nucl Med Mol Imaging; 2004 Aug; 31(8):1182-206. PubMed ID: 15241631
[TBL] [Abstract][Full Text] [Related]
60. Synthesis and biological evaluation of positron emission tomography radiotracers targeting serotonin 4 receptors in brain: [18F]MNI-698 and [18F]MNI-699.
Caillé F; Morley TJ; Tavares AA; Papin C; Twardy NM; Alagille D; Lee HS; Baldwin RM; Seibyl JP; Barret O; Tamagnan GD
Bioorg Med Chem Lett; 2013 Dec; 23(23):6243-7. PubMed ID: 24157369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
